BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38262270)

  • 21. CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis.
    Ohshima K; Kawasaki C; Muta H; Muta K; Deyev V; Haraoka S; Suzumiya J; Podack ER; Kikuchi M
    Histopathology; 2001 Aug; 39(2):156-62. PubMed ID: 11493332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
    Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EZH2 overexpression in primary gastrointestinal diffuse large B-cell lymphoma and its association with the clinicopathological features.
    Liu Y; Yu K; Li M; Zeng K; Wei J; Li X; Liu Y; Zhao D; Fan L; Yu Z; Wang Y; Li Z; Zhang W; Bai Q; Yan Q; Guo Y; Wang Z; Guo S
    Hum Pathol; 2017 Jun; 64():213-221. PubMed ID: 28438623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffuse large B-cell lymphoma.
    Li S; Young KH; Medeiros LJ
    Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma.
    Skacel M; Ross CW; Hsi ED
    Histopathology; 2000 Jul; 37(1):10-8. PubMed ID: 10931213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T follicular helper cell-mediated IL-21 production suppresses FOXP3 expression of T follicular regulatory-like cells in diffuse large B cell lymphoma patients.
    Ma X; Zha J; He J; Chen L; Huang J; Wu W; Tian P; Qian BH; Yu L; Jiang Y; Xu B
    Hum Immunol; 2020 Aug; 81(8):452-459. PubMed ID: 32534760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis.
    Punnoose E; Peale FV; Szafer-Glusman E; Lei G; Bourgon R; Do AD; Kim E; Zhang L; Farinha P; Gascoyne RD; Munoz FJ; Martelli M; Mottok A; Salles GA; Sehn LH; Seymour JF; Trnĕný M; Oestergaard MZ; Mundt KE; Vitolo U
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):267-278.e10. PubMed ID: 33303421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.
    Yokoyama M; Ichinoe M; Okina S; Sakurai Y; Nakada N; Yanagisawa N; Jiang SX; Numata Y; Umezawa A; Miyazaki K; Higashihara M; Murakumo Y
    Int J Hematol; 2017 May; 105(5):614-622. PubMed ID: 28032275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of IL-9 receptor in diffuse large B-cell lymphoma.
    Lv X; Feng L; Fang X; Jiang Y; Wang X
    Int J Clin Exp Pathol; 2013; 6(5):911-6. PubMed ID: 23638223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 10 (IL-10)-producing CD1dhi regulatory B cells from Schistosoma haematobium-infected individuals induce IL-10-positive T cells and suppress effector T-cell cytokines.
    van der Vlugt LE; Zinsou JF; Ozir-Fazalalikhan A; Kremsner PG; Yazdanbakhsh M; Adegnika AA; Smits HH
    J Infect Dis; 2014 Oct; 210(8):1207-16. PubMed ID: 24795476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].
    Xu FP; Liu YH; Zhuang HG; Luo DL; Li L; Zhang F; Luo XL; Du X; Li WY; Chen Q
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):616-21. PubMed ID: 22177246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B-cell lymphoma.
    Ma XB; Zhong YP; Zheng Y; Jiang J; Wang YP
    Cancer Med; 2018 Sep; 7(9):4284-4295. PubMed ID: 30019388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.
    Zhong W; Xu X; Zhu Z; Du Q; Du H; Yang L; Ling Y; Xiong H; Li Q
    Oncotarget; 2017 Jul; 8(30):49757-49772. PubMed ID: 28537908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary adrenal diffuse large B cell lymphoma: a clinicopathological and molecular study from China.
    Zhang J; Sun J; Feng J; Luo Y; Ling Q; Wu S; Zeng X; Liang Z
    Virchows Arch; 2018 Jul; 473(1):95-103. PubMed ID: 29802470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma.
    Xie X; Sundram U; Natkunam Y; Kohler S; Hoppe RT; Kim YH; Cook JR; Hammel J; Swerdlow SH; Guitart J; Smith MD; Bosler D; Listinsky C; Lossos IS; Hsi ED
    Mod Pathol; 2008 Jun; 21(6):653-9. PubMed ID: 18264083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ratio of Immune Response to Tumor Burden Predicts Survival Via Regulating Functions of Lymphocytes and Monocytes in Diffuse Large B-Cell Lymphoma.
    Ji H; Niu X; Yin L; Wang Y; Huang L; Xuan Q; Li L; Zhang H; Li J; Yang Y; An W; Zhang Q
    Cell Physiol Biochem; 2018; 45(3):951-961. PubMed ID: 29428948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunomodulation of human CD19
    Hong M; Liao Y; Liang J; Chen X; Li S; Liu W; Gao C; Zhong Z; Kong D; Deng J; Zhang J; Pan G
    Hum Immunol; 2019 Oct; 80(10):863-870. PubMed ID: 31262519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of CD29 on lymphoma cells and/or CD36 on microvascular endothels correlates with high serum LDH level in diffuse large B-cell lymphomas (DLBCLs) and is frequent in de novo CD5-positive DLBCLs.
    Ueno S; Yamaguchi M; Kimura M; Odagiri H; Shiraki K; Uemoto S; Nakamura N; Zhang W; Shiku H; Kobayashi T
    Int J Oncol; 2005 Nov; 27(5):1241-6. PubMed ID: 16211218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD30 expression and its correlation with MYC and BCL2 in de novo diffuse large B-cell lymphoma.
    Gong QX; Wang Z; Liu C; Li X; Lu TX; Liang JH; Xu W; Li JY; Zhang ZH
    J Clin Pathol; 2018 Sep; 71(9):795-801. PubMed ID: 29666157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.